SCHEMBL5328790

SCHEMBL5328790

O=C1CCCCN1CI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL188184 0.93
SCHEMBL1446405 0.79 L3MBTL1 (0.47)
SCHEMBL3834112 0.78 KMT2A (0.60)
SCHEMBL12139554 0.76
SCHEMBL179071 0.76
SCHEMBL4341665 0.76
SCHEMBL13654900 0.76
SCHEMBL771604 0.76
SCHEMBL1856822 0.76
SCHEMBL9821079 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582692-B1 CYCLOHEXYL-AZETIDINYL ANTAGONISTS OF CCR2 JANSSEN PHARMACEUTICA NV (BE) 2015-07-22 EP disclosed
EP-1730142-B1 NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS SCHERING CORP (US) 2011-06-29 EP disclosed
WO-2007138615-A2 NOVEL PROCESSES FOR PREPARING SERTRALINE HYDROCHLORIDE CRYSTALLINE FORMS HETERO DRUGS LIMITED (IN) 2007-12-06 WO disclosed